Skip to main content
. 2011 Feb 28;29(10):1304–1311. doi: 10.1200/JCO.2010.29.4611

Fig 1.

Fig 1.

Failure-free survival curves for patients who are regional lymph node disease (RLND) negative, patients who are RLND positive, and patients with one site of metastatic disease in (A) both embryonal and alveolar rhabdomyosarcoma (RMS), (B) alveolar RMS only, and (C) embryonal RMS only.